140 related articles for article (PubMed ID: 27038496)
1. Part 3: Notch-sparing γ-secretase inhibitors: SAR studies of 2-substituted aminopyridopyrimidinones.
Zhang J; Lu D; Wei HX; Gu Y; Selkoe DJ; Wolfe MS; Augelli-Szafran CE
Bioorg Med Chem Lett; 2016 May; 26(9):2138-41. PubMed ID: 27038496
[TBL] [Abstract][Full Text] [Related]
2. Part 2. Notch-sparing γ-secretase inhibitors: The study of novel γ-amino naphthyl alcohols.
Wei HX; Lu D; Sun V; Zhang J; Gu Y; Osenkowski P; Ye W; Selkoe DJ; Wolfe MS; Augelli-Szafran CE
Bioorg Med Chem Lett; 2016 May; 26(9):2133-7. PubMed ID: 27020305
[TBL] [Abstract][Full Text] [Related]
3. Part 1: Notch-sparing γ-secretase inhibitors: The identification of novel naphthyl and benzofuranyl amide analogs.
Lu D; Wei HX; Zhang J; Gu Y; Osenkowski P; Ye W; Selkoe DJ; Wolfe MS; Augelli-Szafran CE
Bioorg Med Chem Lett; 2016 May; 26(9):2129-32. PubMed ID: 27013392
[TBL] [Abstract][Full Text] [Related]
4. Proton myo-inositol cotransporter is a novel γ-secretase associated protein that regulates Aβ production without affecting Notch cleavage.
Teranishi Y; Inoue M; Yamamoto NG; Kihara T; Wiehager B; Ishikawa T; Winblad B; Schedin-Weiss S; Frykman S; Tjernberg LO
FEBS J; 2015 Sep; 282(17):3438-51. PubMed ID: 26094765
[TBL] [Abstract][Full Text] [Related]
5. Difluoro ketone peptidomimetics suggest a large S1 pocket for Alzheimer's gamma-secretase: implications for inhibitor design.
Moore CL; Leatherwood DD; Diehl TS; Selkoe DJ; Wolfe MS
J Med Chem; 2000 Sep; 43(18):3434-42. PubMed ID: 10978191
[TBL] [Abstract][Full Text] [Related]
6. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein.
Yang T; Arslanova D; Gu Y; Augelli-Szafran C; Xia W
Mol Brain; 2008 Nov; 1():15. PubMed ID: 18983676
[TBL] [Abstract][Full Text] [Related]
7. TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h.
Hussain I; Harrison DC; Hawkins J; Chapman T; Marshall I; Facci L; Ahmed S; Brackenborough K; Skaper SD; Mead TL; Smith BB; Giblin GM; Hall A; Gonzalez MI; Richardson JC
Neurodegener Dis; 2011; 8(1-2):15-24. PubMed ID: 20689247
[TBL] [Abstract][Full Text] [Related]
8. A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors.
Gay M; Evrard C; Descamps F; Carato P; Renault N; Coevoet M; Eddarkaoui S; Baud C; Larchanché PE; Buée L; El Bakali J; Vingtdeux V; Sergeant N; Melnyk P
Eur J Med Chem; 2018 Nov; 159():104-125. PubMed ID: 30268822
[TBL] [Abstract][Full Text] [Related]
9. Combining an amyloid-beta (Aβ) cleaving enzyme inhibitor with a γ-secretase modulator results in an additive reduction of Aβ production.
Strömberg K; Eketjäll S; Georgievska B; Tunblad K; Eliason K; Olsson F; Radesäter AC; Klintenberg R; Arvidsson PI; von Berg S; Fälting J; Cowburn RF; Dabrowski M
FEBS J; 2015 Jan; 282(1):65-73. PubMed ID: 25303711
[TBL] [Abstract][Full Text] [Related]
10. gamma-Secretase as a therapeutic target in Alzheimer's disease.
Guardia-Laguarta C; Pera M; Lleó A
Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
[TBL] [Abstract][Full Text] [Related]
11. Rac1 changes the substrate specificity of gamma-secretase between amyloid precursor protein and Notch1.
Boo JH; Sohn JH; Kim JE; Song H; Mook-Jung I
Biochem Biophys Res Commun; 2008 Aug; 372(4):913-7. PubMed ID: 18538664
[TBL] [Abstract][Full Text] [Related]
12. (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor.
Cole DC; Stock JR; Kreft AF; Antane M; Aschmies SH; Atchison KP; Casebier DS; Comery TA; Diamantidis G; Ellingboe JW; Harrison BL; Hu Y; Jin M; Kubrak DM; Lu P; Mann CW; Martone RL; Moore WJ; Oganesian A; Riddell DR; Sonnenberg-Reines J; Sun SC; Wagner E; Wang Z; Woller KR; Xu Z; Zhou H; Jacobsen JS
Bioorg Med Chem Lett; 2009 Feb; 19(3):926-9. PubMed ID: 19097890
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
[TBL] [Abstract][Full Text] [Related]
14. Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.
Lewis HD; Pérez Revuelta BI; Nadin A; Neduvelil JG; Harrison T; Pollack SJ; Shearman MS
Biochemistry; 2003 Jun; 42(24):7580-6. PubMed ID: 12809514
[TBL] [Abstract][Full Text] [Related]
15. Aspartate mutations in presenilin and gamma-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling.
Berezovska O; Jack C; McLean P; Aster JC; Hicks C; Xia W; Wolfe MS; Kimberly WT; Weinmaster G; Selkoe DJ; Hyman BT
J Neurochem; 2000 Aug; 75(2):583-93. PubMed ID: 10899933
[TBL] [Abstract][Full Text] [Related]
16. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
[TBL] [Abstract][Full Text] [Related]
17. A novel high throughput 1536-well Notch1 γ -secretase AlphaLISA assay.
Chau DM; Shum D; Radu C; Bhinder B; Gin D; Gilchrist ML; Djaballah H; Li YM
Comb Chem High Throughput Screen; 2013 Jul; 16(6):415-24. PubMed ID: 23448293
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer.
Feng Z; Xu W; Zhang C; Liu M; Wen H
Oncotarget; 2017 Jan; 8(5):8215-8225. PubMed ID: 28030808
[TBL] [Abstract][Full Text] [Related]
19. Γ-secretase modulators do not induce Aβ-rebound and accumulation of β-C-terminal fragment.
Li T; Huang Y; Jin S; Ye L; Rong N; Yang X; Ding Y; Cheng Z; Zhang J; Wan Z; Harrison DC; Hussain I; Hall A; Lee DH; Lau LF; Matsuoka Y
J Neurochem; 2012 Apr; 121(2):277-86. PubMed ID: 22035227
[TBL] [Abstract][Full Text] [Related]
20. Gleevec inhibits beta-amyloid production but not Notch cleavage.
Netzer WJ; Dou F; Cai D; Veach D; Jean S; Li Y; Bornmann WG; Clarkson B; Xu H; Greengard P
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12444-9. PubMed ID: 14523244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
